arrow_back Back Filing freshness 10-Q Q3 FY2015 SEC EDGAR

CTT PHARMACEUTICAL HOLDINGS, INC.

CTTH
Price unavailable
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
34 Visible periods
17 Metrics
Peer-ranked Benchmarks
Price Chart
72
Health
Good
Bullish
auto_awesome

Analytical Summary

CTT PHARMACEUTICAL HOLDINGS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC None
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

34-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-341.93K
↓ -691.6%
FCF / Share Free cash flow per share
$-0.00
↑ +64.3%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
95
Cash Quality
13

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 34 quarters